Scroggie D.A., Albright A., Harris M.D. The Effect of Glucosamine- Chondroitin Supplementation on Glycosylated Hemoglobin Levels in Patients With Type 2 Diabetes MellitusA Placebo-Controlled, Doubleblinded, Randomized Clinical Trial. Arch Intern Med. 2003;163(13):1587–1590. doi: 10.1001/archinte.163.13.1587..
DOI: 10.1001/archinte.163.13.1587
Громова О.А., Торшин И.Ю., Лила А.М. О безопасности применения глюкозамина сульфата у пациентов с резистентностью к инсулину. Consilium Medicum. 2019;21(4):75–83. doi: 10.26442/20751753.2019.4.190309..
DOI: 10.26442/20751753.2019.4.190309
Veronese N., Cooper C., Reginster J.Y., Hochberg M., Branco J., Bruyère O. et al. Type 2 diabetes mellitus and osteoarthritis. Semin Arthritis Rheum. 2019;49(1):9–19. doi: 10.1016/j.semarthrit.2019.01.005..
DOI: 10.1016/j.semarthrit.2019.01.005
Das A. Jr., Hammad T.A. Efficacy of combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000;8(5):343–350. doi: 10.1053/joca.1999.0308..
DOI: 10.1053/joca.1999.0308
Henrotin Y., Mathy M., Sanchez C., Lambert C. Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Ther Adv Musculoskelet Dis. 2010;2(6):335–348. doi: 10.1177/1759720X10383076..
DOI: 10.1177/1759720X10383076
Stellavato A., Restaino O.F., Vassallo V. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent? Adv Ther. 2019;36(11):3221–3237. doi: 10.1007/s12325-019-01064-8..
DOI: 10.1007/s12325-019-01064-8
Walimbe T., Panitch А. Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules. Front Pharmacol. 2020;10:1661. doi: 10.3389/fphar.2019.01661..
DOI: 10.3389/fphar.2019.01661
Balkan B., Dunning B. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes. 1994;43(10):1173–1179. doi: 10.2337/diab.43.10.1173..
DOI: 10.2337/diab.43.10.1173
Rodgers M.R. Effects of Oral Glucosamine and Chondroitin Sulfates Supplementation on Frequency of Intra-articular Therapy of the Horse Tarsus. Intern J Appl Res Vet Med. 2006;4(2):155–162. Available at: http://www.jarvm.com/articles/Vol4Iss2/Rodgers.pdf.http://www.jarvm.com/articles/Vol4Iss2/Rodgers.pdf
Rodgers M.R. Effects of Oral Glucosamine and Chondroitin Sulfates Supplementation on Frequency of Intra-articular Therapy of the Horse Tarsus. Intern J Appl Res Vet Med. 2006;4(2):155–162. Available at: http://www.jarvm.com/articles/Vol4Iss2/Rodgers.pdf.https://www.rmj.ru/articles/revmatologiya/Mesto_preparatov_hondroitina_sulyfata_Hondroksid_i_dr_v_arsenale_sredstv_dlya_lecheniya_osteoartroza/
Горячев Д.В. Место препаратов хондроитина сульфата (Хондроксид и др.) в арсенале средств для лечения остеоартроза. РМЖ. 2008;(10):693. Режим доступа: https://www.rmj.ru/articles/revmatologiya/Mesto_preparatov_hondroitina_sulyfata_Hondroksid_i_dr_v_arsenale_sredstv_dlya_lecheniya_osteoartroza/.https://www.rmj.ru/articles/revmatologiya/Mesto_preparatov_hondroitina_sulyfata_Hondroksid_i_dr_v_arsenale_sredstv_dlya_lecheniya_osteoartroza/
Горячев Д.В. Место препаратов хондроитина сульфата (Хондроксид и др.) в арсенале средств для лечения остеоартроза. РМЖ. 2008;(10):693. Режим доступа: https://www.rmj.ru/articles/revmatologiya/Mesto_preparatov_hondroitina_sulyfata_Hondroksid_i_dr_v_arsenale_sredstv_dlya_lecheniya_osteoartroza/.http://www.fesmu.ru/elib/Article.aspx?id=165048
Шкарина Т.Н., Исаева И.В., Ковалева С.В. Лекарственные средства, содержащие хондроитин сульфат. Фармация. 2007;(3):42–48. Режим доступа: http://www.fesmu.ru/elib/Article.aspx?id=165048..
DOI: 10.1016/j.pharmthera.2014.01.002http://www.fesmu.ru/elib/Article.aspx?id=165048
du Souich P. Absorption, distribution and mechanism of action of SYSADOAS. Pharmacol Ther. 2014;142(3):362–374. doi: 10.1016/j.pharmthera.2014.01.002..
DOI: 10.1016/j.pharmthera.2014.01.002https://www.jstage.jst.go.jp/article/cpb/64/5/64_c15-00940/_article/-char/en
Ge D., Higashi K., Ito D., Nagano K., Ishikawa R., Terui Y., Higashi K., Moribe K., Linhardt R.J., Toida T. Poly-ion Complex of Chondroitin Sulfate and Spermine and Its Effect on Oral Chondroitin Sulfate Bioavailability. Chem Pharm Bull (Tokyo). 2016;64(5):390–398. Available at: https://www.jstage.jst.go.jp/article/cpb/64/5/64_c15-00940/_article/-char/en..
DOI: 10.1016/j.ijbiomac.2016.01.055https://www.jstage.jst.go.jp/article/cpb/64/5/64_c15-00940/_article/-char/en
Shang Q., Yin Y., Zhu L., Li G., Yu G., Wang X. Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. Int J Biol Macromol. 2016;86:112–118. doi: 10.1016/j.ijbiomac.2016.01.055..
DOI: 10.1016/j.ijbiomac.2016.01.055
Shang Q., Yin Y., Zhu L., Li G., Yu G., Wang X. Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. Int J Biol Macromol. 2016;86:112–118. doi: 10.1016/j.ijbiomac.2016.01.055..
DOI: 10.1016/j.ijpharm.2014.02.009
Xiao Y., Li P., Cheng Y., Zhang X., Sheng J., Wang D. et al. Enhancing the intestinal absorption of low molecular weight chondroitin sulfate by conjugation with α-linolenic acid and the transport mechanism of the conjugates. Int J Pharm. 2014;465(1–2):143–158. doi: 10.1016/j.ijpharm.2014.02.009..
DOI: 10.1016/j.ijpharm.2014.02.009
Xiao Y., Li P., Cheng Y., Zhang X., Sheng J., Wang D. et al. Enhancing the intestinal absorption of low molecular weight chondroitin sulfate by conjugation with α-linolenic acid and the transport mechanism of the conjugates. Int J Pharm. 2014;465(1–2):143–158. doi: 10.1016/j.ijpharm.2014.02.009..
DOI: 10.1016/j.carbpol.2019.115496
Lin T.S., Hsieh C.H., Kuo C., Juang Y.P., Hsieh Y.S.Y., Chiang H. et al. Sulfation pattern of chondroitin sulfate in human osteoarthritis cartilages reveals a lower level of chondroitin-4-sulfate. Carbohydr Polym. 2020;229:115496. doi: 10.1016/j.carbpol.2019.115496..
DOI: 10.1016/j.carbpol.2019.115496
Lin T.S., Hsieh C.H., Kuo C., Juang Y.P., Hsieh Y.S.Y., Chiang H. et al. Sulfation pattern of chondroitin sulfate in human osteoarthritis cartilages reveals a lower level of chondroitin-4-sulfate. Carbohydr Polym. 2020;229:115496. doi: 10.1016/j.carbpol.2019.115496..
DOI: 10.1055/s-0031-1300180
Omata T., Itokazu Y., Inoue N., Segawa Y. Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. Arzneimittelforschung. 2000;50(2):148–153. doi: 10.1055/s-0031-1300180..
DOI: 10.1055/s-0031-1300180
Omata T., Itokazu Y., Inoue N., Segawa Y. Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. Arzneimittelforschung. 2000;50(2):148–153. doi: 10.1055/s-0031-1300180..
DOI: 10.1177/153537020523000405
Chou M.M., Vergnolle N., McDougall J.J., Wallace J.L., Marty S., Teskey V., Buret A.G. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med. 2005;230(4):255–262. doi: 10.1177/153537020523000405..
DOI: 10.1177/153537020523000405
Chou M.M., Vergnolle N., McDougall J.J., Wallace J.L., Marty S., Teskey V., Buret A.G. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med. 2005;230(4):255–262. doi: 10.1177/153537020523000405..
DOI: 10.1002/jcb.21981
Campo G.M., Avenoso A., Campo S., D’ Ascola A., Traina P., Sama D. et al. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem. 2009;106(1):83–92. doi: 10.1002/jcb.21981..
DOI: 10.1002/jcb.21981
Campo G.M., Avenoso A., Campo S., D’ Ascola A., Traina P., Sama D. et al. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem. 2009;106(1):83–92. doi: 10.1002/jcb.21981..
DOI: 10.1248/bpb.27.47
Cho S.Y., Sim J.S., Jeong C.S., Chang S.Y., Choi D.W., Toida T., Kim Y.S. Effects of low molecular weight chondroitin sulfate on type II collagen–induced arthritis in DBA/1J mice. Biol Pharm Bull. 2004;27(1):47–51. doi: 10.1248/bpb.27.47..
DOI: 10.1248/bpb.27.47
Cho S.Y., Sim J.S., Jeong C.S., Chang S.Y., Choi D.W., Toida T., Kim Y.S. Effects of low molecular weight chondroitin sulfate on type II collagen–induced arthritis in DBA/1J mice. Biol Pharm Bull. 2004;27(1):47–51. doi: 10.1248/bpb.27.47..
DOI: 10.1002/art.24302
David-Raoudi M., Deschrevel B., Leclercq S., Galéra P., Boumediene K., Pujol J.P. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. Arthr Rheum. 2009;60(3):760–770. doi: 10.1002/art.24302..
DOI: 10.1002/art.24302
David-Raoudi M., Deschrevel B., Leclercq S., Galéra P., Boumediene K., Pujol J.P. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. Arthr Rheum. 2009;60(3):760–770. doi: 10.1002/art.24302..
DOI: 10.1016/j.atherosclerosis.2015.12.016
Melgar-Lesmes P., Garcia-Polite F., Del-Rey-Puech P., Rosas E., Dreyfuss J.L., Montell E. et al. Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity. Atherosclerosis. 2016;245:82–87. doi: 10.1016/j.atherosclerosis.2015.12.016..
DOI: 10.1016/j.atherosclerosis.2015.12.016
Melgar-Lesmes P., Garcia-Polite F., Del-Rey-Puech P., Rosas E., Dreyfuss J.L., Montell E. et al. Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity. Atherosclerosis. 2016;245:82–87. doi: 10.1016/j.atherosclerosis.2015.12.016..
DOI: 10.1002/acr.24131
Kolasinski S.L., Neogi T., Hochberg M.C., Oatis C., Guyatt G., Block J. et al. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72(2):220–233. doi: 10.1002/acr.24131..
DOI: 10.1002/acr.24131
Kolasinski S.L., Neogi T., Hochberg M.C., Oatis C., Guyatt G., Block J. et al. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72(2):220–233. doi: 10.1002/acr.24131..
DOI: 10.1089/jmf.2019.0022
Grzanna M.W., Au R.Y., Au A.Y., Rashmir A.M., Frondoza C.G. Avocado/ Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination Inhibits Proinflammatory COX-2 Expression and Prostaglandin E2 Production in Tendon-Derived Cells. J Med Food. 2020;23(2):139–146. doi: 10.1089/jmf.2019.0022..
DOI: 10.1089/jmf.2019.0022https://medvestnik.ru/apps/mv/assets/uploads/Статьи/REK-osteo2016.pdf
Наумов В.А., Алексеева Л.И. Ведение больных с остеоартритом и коморбидностью в общей врачебной практике. Клинические рекомендации. М.; 2016. 37 с. Режим доступа: https://medvestnik.ru/apps/mv/assets/uploads/Статьи/REK-osteo2016.pdf..
DOI: 10.1056/NEJMoa052771https://medvestnik.ru/apps/mv/assets/uploads/Статьи/REK-osteo2016.pdf
Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O’Dell J.R., Hooper M.M. et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795–808. doi: 10.1056/NEJMoa052771..
DOI: 10.1056/NEJMoa052771
Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O’Dell J.R., Hooper M.M. et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795–808. doi: 10.1056/NEJMoa052771..
DOI: 10.1136/annrheumdis-2014-206792
Hochberg M.C., Martel-Pelletier J., Monfort J., Möller I., Castillo J.R., Arden N. et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37–44. doi: 10.1136/annrheumdis-2014-206792..
DOI: 10.1136/annrheumdis-2014-206792
Hochberg M.C., Martel-Pelletier J., Monfort J., Möller I., Castillo J.R., Arden N. et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37–44. doi: 10.1136/annrheumdis-2014-206792..
DOI: 10.1177/2040622319870013
Blanco F.J., Camacho-Encina M., González-Rodríguez L., Rego-Pérez I., Mateos J., Fernández-Puente P. et al. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis. Ther Adv Chronic Dis. 2019;10:2040622319870013. doi: 10.1177/2040622319870013..
DOI: 10.1177/2040622319870013
Blanco F.J., Camacho-Encina M., González-Rodríguez L., Rego-Pérez I., Mateos J., Fernández-Puente P. et al. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis. Ther Adv Chronic Dis. 2019;10:2040622319870013. doi: 10.1177/2040622319870013..
DOI: 10.1002/art.39819
Marcus D.M. Chondroitin sulfate for knee osteoarthritis. Annals of the Rheumatic Diseases. 2018;77(6):e27. doi: 10.1002/art.39819. 30. Алексеева Л.И. Хондроитин сульфат в лечении остеоартроза. РМЖ. 2007;(8):642. Режим доступа: https://www.rmj.ru/articles/revmatologiya/Hondroitin_sulyfat_v_lechenii_osteoartroza/..
DOI: 10.1002/art.39819. 30. Алексеева Л.И. Хондроитин сульфат в лечении остеоартроза. РМЖ. 2007;(8):642https://www.rmj.ru/articles/revmatologiya/Hondroitin_sulyfat_v_lechenii_osteoartroza/
Marcus D.M. Chondroitin sulfate for knee osteoarthritis. Annals of the Rheumatic Diseases. 2018;77(6):e27. doi: 10.1002/art.39819. 30. Алексеева Л.И. Хондроитин сульфат в лечении остеоартроза. РМЖ. 2007;(8):642. Режим доступа: https://www.rmj.ru/articles/revmatologiya/Hondroitin_sulyfat_v_lechenii_osteoartroza/..
DOI: 10.1002/art.39819. 30. Алексеева Л.И. Хондроитин сульфат в лечении остеоартроза. РМЖ. 2007;(8):642https://www.rmj.ru/articles/revmatologiya/Hondroitin_sulyfat_v_lechenii_osteoartroza/
Цветкова Е.С., Иониченок Н.Г., Денисов Л.Н. Современная фармакотерапия остеоартроза коленных суставов: особенности симптоматического и болезнь-модифицирующего действия. Сообщение 1. Особенности симптоматического действия современных препаратов при остеоартрозе коленных суставов. Научно-практическая ревматология. 2015;53(1):63–68. Режим доступа: https://rsp.ima-press.net/rsp/article/viewFile/2040/1286.https://rsp.ima-press.net/rsp/article/viewFile/2040/1286
Цветкова Е.С., Иониченок Н.Г., Денисов Л.Н. Современная фармакотерапия остеоартроза коленных суставов: особенности симптоматического и болезнь-модифицирующего действия. Сообщение 1. Особенности симптоматического действия современных препаратов при остеоартрозе коленных суставов. Научно-практическая ревматология. 2015;53(1):63–68. Режим доступа: https://rsp.ima-press.net/rsp/article/viewFile/2040/1286.https://rsp.ima-press.net/rsp/article/view-File/2040/1286